MiniMed Group Inc. (MMED) exhibits 54.2% gross margins and -3.9% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 24.0x enterprise multiple and 7.1% implied options volatility.
Sustained 54.2% gross profitability converts into -6.1% operating margin and -3.9% ROIC, outpacing sector cost of capital.
ROIC: -3.9% // GM: 54.2%YoY revenue trajectory of +14.3% paired with -7.75% free cash flow yield supports self-funded R&D and capital return.
REV YOY: +14.3% // FCF YLD: -7.75%Altman Z-Score of 4.82 and Piotroski F-Score of 5/9 indicate low near-term refinancing stress.
ALTMAN Z: 4.82 // F-SCORE: 5/9Trading at 24.0x trailing P/E (24.0x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: —Options market prices a ±7.1% implied move with a 0.75 put/call ratio around $19.00 max pain.
IMPL MOVE: ±7.1% // P/C: 0.75Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend -10.7% net margins.
NET MARGIN: -10.7% // D/E: 0.11x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for MMED & activate live FRED threshold breach alerts.